BOSTIK HYTEC P510 RENORAPID

Hazard statements (CLP)

H315, H317, H319, H332, H334, H335, H351, H373

Code

Statements

H315

Causes skin irritation

SECTION 2: Hazards identification

Classification of the substance or mixture GB CLP (SI 2020/1567 as amended) Acute toxicity - Inhalation (Dusts/Mists) Category 4 - (H332) Skin corrosion/irritation Category 2 - (H315) Serious eye damage/eye irritation Category 2 - (H319) Respiratory sensitisation Category 1 - (H334) Skin sensitisation Category 1 - (H317) Carcinogenicity Category 2 - (H351) Specific target organ toxicity — single exposure Category 3 - (H335) Category 3 Respiratory irritation Specific target organ toxicity — repeated exposure Category 2 - (H373)

Contains

Prepolymer, based on aromatic polyisocyanate, 4,4'-Methylenediphenyl diisocyanate, o-(p-isocyanatobenzyl)phenyl isocyanate, Diphenylmethane-diisocyanate, isomers and homologues

Signal word

Danger

Hazard statements

H315 - Causes skin irritation. H317 - May cause an allergic skin reaction. H319 - Causes serious eye irritation. H332 - Harmful if inhaled. H334 - May cause allergy or asthma symptoms or breathing difficulties if inhaled. H335 - May cause respiratory irritation. H351 - Suspected of causing cancer. H373 - May cause damage to organs through prolonged or repeated exposure.

Precautionary statements

P260 - Do not breathe mist/vapours/spray P280 - Wear protective gloves/protective clothing/eye protection/face protection P304 + P340 - IF INHALED: Remove person to fresh air and keep comfortable for breathing P302 + P352 - IF ON SKIN: Wash with plenty of water and soap P305 + P351 + P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing P402 + P404 - Store in a dry place. Store in a closed container P501 - Dispose of contents/ container to an approved waste disposal plant

Special rules for supplemental label elements for certain mixtures

Reserved for industrial and professional use. As from 24 August 2023 adequate training is required before industrial or professional use. Persons already sensitised to diisocyanates may develop allergic reactions when using this product. Persons suffering from asthma, eczema or skin problems should avoid contact, including dermal contact, with this product. This product should not be used under conditions of poor ventilation unless a protective mask with an appropriate gas filter (i.e. type A1 according to standard EN 14387) is used.

Additional information

This product requires tactile warnings if supplied to the general public.

2.3 Other hazards

No information available.

PBT Substances

& vPvB This mixture contains no substance considered to be persistent, bioaccumulating or toxic (PBT). This mixture contains no substance considered to be very persistent nor very bioaccumulating (vPvB).

2.1 Classification of the substance or mixture

GB CLP (SI 2020/1567 as amended) Acute toxicity - Inhalation (Dusts/Mists) Category 4 - (H332) Skin corrosion/irritation Category 2 - (H315) Serious eye damage/eye irritation Category 2 - (H319) Respiratory sensitisation Category 1 - (H334) Skin sensitisation Category 1 - (H317) Carcinogenicity Category 2 - (H351) Specific target organ toxicity — single exposure Category 3 - (H335) Category 3 Respiratory irritation Specific target organ toxicity — repeated exposure Category 2 - (H373)